Diagnostic Imaging Centers of Texas and VoxNeuro Collaborate to Advance Patient Care Through Integrated Imaging and Brain-Function Assessment
Diagnostic Imaging Centers of Texas (DICOT or the Company) today announced an expanded collaboration with VoxNeuro Inc. aimed at advancing a more integrated approach to evaluating patients recovering from motor vehicle collisions, workplace incidents, and other traumatic injuries. By combining DICOT's diagnostic imaging and patient care platform in Southeast Texas - delivered through its Memorial MRI & Diagnostic and Foundation Physicians Group brands - with VoxNeuro's FDA-cleared Cognitive Function Neuroimaging (cfNI) Software, the collaboration seeks to provide a more complete picture of injury, helping physicians identify what standard evaluation alone can miss. The two modalities offer complementary perspectives: MRI, CT, and ultrasound reveal the structural anatomy of an injury, while cfNI contributes an objective clinical software platform to measure brain function.
VoxNeuro Receives FDA 510(k) Clearance for Cognitive Function Neuroimaging (cfNI) Software - An Objective EEG/ERP Brain Health Assessment
VoxNeuro Inc. (the Company) today announced that the U.S. Food and Drug Administration has granted 510(k) clearance for its Cognitive Function Neuroimaging (cfNI) software, a prescription-use Software-as-a-Medical-Device (SaMD) that provides digital, post-hoc statistical analysis of electroencephalography (EEG), including event-related potentials (ERPs), in adults ages 18 to 70.
VoxNeuro Raises $3.4M to Accelerate Scaling Its Brain Performance Software Across US Clinics
VoxNeuro Inc. (“VoxNeuro” or “the Company”), a company that develops leading-edge EEG-based brain performance software, announced the completion of its second financing round with nearly USD $3.4 million raised. The funding round was led by the Company’s largest shareholder, in addition to its strategic investor g.tec, a brain-computer interface and neurotechnology company that serves as VoxNeuro's strategic supplier of EEG hardware. The financing will be used to execute commercial expansion plans to scale clinical installations across the US to meet the growing demand for cognitive assessments, promote brain health equity, and continue to perform software enhancements through research and development.
